TY - JOUR
AU - F. Safi
AU - W. Rioux
AU - N. Rider
AU - B. Fornssler
AU - S. Jones
AU - S. M. Ghosh
A1 - 
AD - Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada.; Department of Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.; School of Public Health, University of Saskatchewan, Saskatoon, Canada.; Three Hive Consulting, Vancouver, BC, Canada.; Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada. ghosh@ualberta.ca.; Department of Internal Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada. ghosh@ualberta.ca.
AN - 37158926
BT - Harm Reduct J
C5 - Opioids & Substance Use
CP - 1
DA - May 8
DO - 10.1186/s12954-023-00792-z
DP - NLM
ET - 20230508
IS - 1
JF - Harm Reduct J
LA - eng
PY - 2023
SN - 1477-7517
SP - 64
ST - Feasibility and acceptability of inserts promoting virtual overdose monitoring services (VOMS) in naloxone kits: a qualitative study
T1 - Feasibility and acceptability of inserts promoting virtual overdose monitoring services (VOMS) in naloxone kits: a qualitative study
T2 - Harm Reduct J
TI - Feasibility and acceptability of inserts promoting virtual overdose monitoring services (VOMS) in naloxone kits: a qualitative study
U1 - Opioids & Substance Use
U3 - 10.1186/s12954-023-00792-z
VL - 20
VO - 1477-7517
Y1 - 2023
ER -